Meanwhile, 131 patients (62.1%) in the study population had stage I lung adenocarcinoma, and our results further revealed that DRP1 and P(S616)‐DRP1 expression remained significantly associated with postoperative recurrence in patients with early‐stage lung adenocarcinoma (Fig. S2C–F). This evidence concerns the gene DNM1L and lung adenocarcinoma.